Trastuzumab Deruxtecan for the Treatment of HER2 Breast Cancer

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=6FR0DM1uq6U

Safety and efficacy results from the pivotal phase II DESTINY-Breast01 trial of trastuzumab deruxtecan for the treatment of HER2+ metastatic breast cancer after failure of 2 prior lines of therapy. • For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

#############################

New on site